Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L9AJ
|
||||
Former ID |
DCL000982
|
||||
Drug Name |
Seletracetam
|
||||
Synonyms |
UCB 44212; UCB-44212; 2-[4-(2,2-difluoroethenyl)-2-oxo-pyrrolidin-1-yl]butanamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy [ICD10:G40] | Discontinued in Phase 3 | [536498] | ||
Company |
UCB Pharma
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H14F2N2O2
|
||||
Canonical SMILES |
CCC(C(=O)N)N1CC(CC1=O)C=C(F)F
|
||||
InChI |
1S/C10H14F2N2O2/c1-2-7(10(13)16)14-5-6(3-8(11)12)4-9(14)15/h3,6-7H,2,4-5H2,1H3,(H2,13,16)/t6-,7+/m1/s1
|
||||
InChIKey |
ANWPENAPCIFDSZ-RQJHMYQMSA-N
|
||||
CAS Number |
CAS 357336-74-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Synaptic vesicle glycoprotein 2A | Target Info | Binder | [536498] | |
KEGG Pathway | ECM-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.